Category: Recent News

Fremont, California August 25, 2014 /PRNewswire-iReach/ – Arbor Vita Corporation, a privately held company, announced today results presented at the 29th International Papillomavirus (IPV) Conference based on the groundbreaking OncoE6TM proteomic-based diagnostics platform applied to diverse clinical settings.  Presentations were given by Charite University Hospital in Berlin, Catholic Hospital Battor (Ghana), the German Cancer Research Center, and Arbor Vita Corporation.… Continue reading Study Results Using OncoE6™ Oral and Cervical Tests Presented at the International Papillomavirus Conference

Fremont, California [September 3, 2014] — Arbor Vita Corporation, a privately held company, announced today that AB ANALITICA will distribute the OncoE6TM Cervical Test in Italy.  OncoE6TM Cervical Test is a new point-of-care proteomics diagnostic that supplements current cervical cancer screening technologies. Cervical cancer remains one of the major causes of cancer-related death in women.  All such cancers originate from Human… Continue reading Arbor Vita Corporation Signs Distribution Agreement with AB ANALITICA

Fremont, California [October 22, 2014] – Arbor Vita Corporation, a privately held company, presented its groundbreaking OncoE6TM Cervical Test, a new point-of-care proteomic-based diagnostic, to participants at the Seventh Scientific Conference of the French Association for the Study of Papillomavirus and Polyomavirus Infections (AFIPP) held in Sete, France.  Cervical cancer remains one of the major causes of cancer-related… Continue reading The OncoE6™ Cervical Test Presented to the French Association for the Study of Papillomavirus and Polyomavirus Infections (AFIPP)

Fremont, California [February 4, 2015] – Arbor Vita Corporation, a privately held company, is presenting its groundbreaking OncoE6TM Cervical Test, a new point-of-care proteomic-based diagnostic, to participants at the EUropean Research Organisation on Genital Infection and Neoplasia (EUROGIN) held on February 4-7, 2015 in Sevilla, Spain.  Cervical cancer remains one of the major causes of cancer-related deaths in… Continue reading The OncoE6™Cervical Test Presented at EUROGIN

Highlighting the increasing burden of cervical cancer among women, health minister J P Nadda said 62,416 women died of the disease in 2015-16, accounting for order steroids online 24% of all cancer cases in women in India. Read the full story here.

Joey was just 40 when she died, and her struggle, which was documented by her husband Rory on his blog, This Life I Live, attracted attention from around the world. The country star, who was part of the duo Joey + Rory, was diagnosed with cervical cancer in May buy steroids canada 2014, just months after giving… Continue reading Country Singer Joey Feek Died From Cervical Cancer—What You Need To Know

Cancers that arise in poorer countries are far less likely to be survived; A disproportionately large number of these cases are caused by infectious agents. Look at the international maps, and pick the ones showing the worldwide incidence of cervical cancer, which is brought on by infection with the human papilloma virus. Read the full… Continue reading In Developing World, Cancer Is a Very Different Disease

Researchers used the National Cancer Data Base, a hospital-based registry of about 70 percent of all cancer cases in the United States. They compared diagnoses for women ages 21 to 25 who had cervical cancer with those for women ages 26 to 34, before and after the health law provision began in 2010. Early-stage diagnoses… Continue reading Rise in Early Cervical Cancer Detection Is Linked to Affordable Care Act

Laura Musselwhite, an internal medicine resident in the Hubert-Yeargan Center’s Global Health Pathway, will be the principal investigator for a recently awarded Grand Challenges Explorations (GCE) grant, an initiative of the Bill & Melinda Gates Foundation. The project aims to tackle the early diagnosis of cervical cancer, a leading cause of cancer deaths in women… Continue reading Global Health Resident to Lead Cervical Cancer Project Funded by a Grand Challenges Explorations Grant